⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL163401 | 1.00 | — | — | |
| SCHEMBL77336 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL113877 | 0.98 | ACE (0.46) | — | |
| Water SCHEMBL2694310 | 0.98 | ACE (0.46) | — | |
| Bromide SCHEMBL6632312 | 0.98 | ACE (0.46) | — | |
| Water SCHEMBL1598128 | 0.98 | ACE (0.46) | — | |
| Hydrochloric Acid SCHEMBL113878 | 0.98 | ACE (0.46) | — | |
| Water SCHEMBL1598131 | 0.98 | ACE (0.46) | — | |
| Hydrochloric Acid SCHEMBL1721046 | 0.98 | ACE (0.46) | — | |
| SCHEMBL26612359 | 0.98 | ACE (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2133 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-20250361490-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | CELLVIE AG (CH) | 2025-11-27 | — | — | US | claimed |
| EP-4615837-A1 | USEFUL COMPOUNDS FOR MODULATING INFLAMMATION | Flagship Pioneering Innovations VI, LLC (US) | 2025-09-17 | — | — | EP | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| US-20250147048-A1 | METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2025-05-08 | — | — | US | claimed |
| EP-4535996-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | cellvie AG (CH) | 2025-04-16 | — | — | EP | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| CN-119365073-A | Compositions and methods for cryopreserving mitochondria | 赛立维公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119177441-A | Nonferrous metal electroplating material and preparation process thereof | 深圳市生利科技有限公司 | 2024-12-24 | — | — | CN | claimed |
| WO-2024239704-A1 | SOLAR CELL, SOLAR CELL MODULE, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-11-28 | — | — | WO | claimed |
| US-20030216410-A1 | Combination therapy for the treatment of cancer | PHARMACIA CORPORATION | 2003-11-20 | — | — | US | claimed |
| US-20030153611-A1 | 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof | AVENTIS PHARMA S.A. | 2003-08-14 | — | — | US | claimed |
| WO-2003048106-A2 | 1,3-DIARYLPROP-2-EN-1-ONES, COMPOSITIONS CONTAINING SAME AND USE THEREOF | AVENTIS PHARMA S.A. (FR) | 2003-06-12 | — | — | WO | claimed |
| WO-2003015608-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | SUGEN, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| US-20020198156-A1 | Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2002-12-26 | — | — | US | claimed |
| WO-2002074050-A2 | ASYMMETRIC SYNTHESIS OF (S, S, R)-(-)-ACTINONIN AND ITS ANALOGS AND USES THEREFOR | SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2002-09-26 | — | — | WO | claimed |
| US-5665371-A | SIDE EFFECT REDUCTION | HOERRMANN WILHELM (DE) | 1997-09-09 | — | — | US | claimed |
| EP-0422937-B1 | Fibrinogen receptor antagonists | MERCK & CO INC (US) | 1994-03-02 | — | — | EP | claimed |
| EP-0422937-A1 | Fibrinogen receptor antagonists | MERCK & CO. INC. (US) | 1991-04-17 | — | — | EP | claimed |
| US-4336249-A | MYCOPLANECIN PRODUCT CULTIVATED FORM ACTINOPLANES | SANKYO COMPANY LIMITED (JP) | 1982-06-22 | — | — | US | claimed |